Terms: = Ovarian germ cell tumor AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
13 results:
1. ovarian Mucinous Carcinoma with a Yolk sac tumor-Like Component: A Report of Three Cases with a Literature Review for Prognostic Analysis.
Tsujimura M; Fujimoto M; Minamiguchi S; Miyamoto T; Ueda A; Hamanishi J; Mandai M; Haga H
Int J Surg Pathol; 2023 Aug; 31(5):765-771. PubMed ID: 36314449
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Evidence for Epithelial Origin of Mixed ovarian Epithelial-germ cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.
Zong X; Zhang Y; Peng X; Cao D; Yu M; Wang J; Li H; Guo X; Liang H; Yang J
Nat Commun; 2021 Jun; 12(1):3579. PubMed ID: 34117242
[TBL] [Abstract] [Full Text] [Related]
4. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
[TBL] [Abstract] [Full Text] [Related]
5. The Driver Mutational Landscape of ovarian Squamous cell Carcinomas Arising in Mature Cystic Teratoma.
Cooke SL; Ennis D; Evers L; Dowson S; Chan MY; Paul J; Hirschowitz L; Glasspool RM; Singh N; Bell S; Day E; Kochman A; Wilkinson N; Beer P; Martin S; Millan D; Biankin AV; McNeish IA;
Clin Cancer Res; 2017 Dec; 23(24):7633-7640. PubMed ID: 28954785
[No Abstract] [Full Text] [Related]
6. Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
Ow GS; Ivshina AV; Fuentes G; Kuznetsov VA
Cell Cycle; 2014; 13(14):2262-80. PubMed ID: 24879340
[TBL] [Abstract] [Full Text] [Related]
7. Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma.
Gütgemann I; Lehman NL; Jackson PK; Longacre TA
Mod Pathol; 2008 Apr; 21(4):445-54. PubMed ID: 18204430
[TBL] [Abstract] [Full Text] [Related]
8. [Overexpression and prognostic value of p53 and HER2/neu proteins in benign ovarian tissue and in ovarian cancer].
Coronado Martín PJ; Fasero Laiz M; García Santos J; Ramírez Mena M; Vidart Aragón JA
Med Clin (Barc); 2007 Jan; 128(1):1-6. PubMed ID: 17266884
[TBL] [Abstract] [Full Text] [Related]
9. Primary ovarian trabecular carcinoid tumour: a case report with an immunohistochemical study and a review of the literature.
De la Torre J; García A; Castellví J; López M; Gil A
Arch Gynecol Obstet; 2004 Dec; 270(4):274-7. PubMed ID: 12774237
[TBL] [Abstract] [Full Text] [Related]
10. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors of patients with yolk sac tumors of the ovary.
Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
[TBL] [Abstract] [Full Text] [Related]
12. [p53 protein expression in malignant germ cell tumor of ovary and its relationship with clinical course and prognosis].
Gao G; Peng Z; Wang H; Chen A; Yao X
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Dec; 28(4):420-3. PubMed ID: 10683959
[TBL] [Abstract] [Full Text] [Related]
13. Deletion mapping on chromosome 17p in medulloblastoma.
Steichen-Gersdorf E; Baumgartner M; Kreczy A; Maier H; Fink FM
Br J Cancer; 1997; 76(10):1284-7. PubMed ID: 9374372
[TBL] [Abstract] [Full Text] [Related]
